Search
for
Sort by
Research 61–90 of 1000+
- Cutaneous Reactions to Drugs
- ADVERSE EFFECTS OF OPIOID ANALGESIC DRUGS
- Adverse events related to platelet-rich plasma therapy and future issues to be resolved
- Cutaneous adverse effects of BRAF inhibitors in metastatic malignant melanoma, a prospective study in 20 patients.
- Dermatological adverse events with taxane chemotherapy
- Clinical management of cutaneous adverse events in patients on targeted anticancer therapies and immunotherapies: a national consensus statement by the Spanish Academy of Dermatology and Venereology and the Spanish Society of Medical Oncology
- Prospective Case Series of Cutaneous Adverse Effects Associated With Dabrafenib and Trametinib
- Cutaneous Adverse Events of Targeted Anticancer Therapy: A Review of Common Clinical Manifestations and Management
- Dermatologic adverse effect of subcutaneous furosemide administration in a cat
- Adverse Effects and Drug Interactions of Biologic Agents
- Cutaneous adverse events to systemic antineoplastic therapies: a retrospective study in a public oncologic hospital
- Chemotherapy-related adverse effects with anthracycline and taxane-containing regimens in patients with localized Breast cancer: a descriptive study
- Dermatological Adverse Effects of Covid-19 Vaccine among Healthcare Workers: Findings from a Tertiary Care Hospital in Northern India
- (719) Signal Detection of Depression and Suicidality With the 5-Alpha Reductase Inhibitors: Evidence from the Food and Drug Administration (FDA) Adverse Event Reporting System (FAERS) Database
- Diagnosis and treatment of cutaneous adverse effects of targeted therapy, antibody–drug conjugates, and immunotherapy in cancer patients: a national consensus statement by the Spanish Society of Medical Oncology and the Spanish Academy of Dermatology and Venereology
- Cutaneous Adverse Events of Tyrosine Kinase Inhibitors in Endocrine Tumors: Clinical Features, Mechanisms, and Management Strategies
- A Prospective Study of Cutaneous Adverse Events Induced by Low-Dose Alpha-Interferon Treatment for Malignant Melanoma
- Dermatologic adverse events associated with chemotherapy and targeted anticancer therapy
- The incidence and management of cutaneous adverse events of the epidermal growth factor receptor inhibitors
- Trans-Epidermal Elimination Due to Insulin Formulation: Report of a Rare Adverse Effect
- In silico prediction of prostaglandin D2 synthase inhibitors from herbal constituents for the treatment of hair loss
- New Methodology and Instrumentation for Follicular Unit Extraction: Lower Follicle Transection Rates and Expanded Patient Candidacy
- Mesotherapy: Safety profile and management of complications
- Changes in European Legislation Make it Timely to Introduce a Transparent Market Surveillance System for Cosmetics
- Efficacy and safety of minoxidil 3% lotion for beard enhancement: A randomized, double‐masked, placebo‐controlled study
- Long-term (10-year) efficacy of finasteride in 523 Japanese men with androgenetic alopecia
- Clinical Efficacy and Safety of Pulsed Dye Laser Combined with Pingyangmycin on Hyperplastic Scar after Acne
- Organizadores e cortadores de comprimidos: riscos e restrições ao uso
- Platelet-Rich Plasma for Androgenetic Alopecia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
- The efficacy of topical prostaglandin analogs for hair loss: A systematic review and meta-analysis